Roseman Labs’ Post

View organization page for Roseman Labs, graphic

3,372 followers

🛣️ 🎟️ Roseman Labs has had a busy few months travelling all over the Netherlands (and Europe!). If you missed us anywhere, here's a brief recap of what we've been up to: 🔗 ICT&health: presenting the Nederlandse Vereniging van Podotherapeuten Podiatry case with Femke van den Wall Bake, Roy Wisselink and Freya de Mink! 🏥 NHS Expo: Häusler-Leutgeb Michael in Manchester with the Netherlands Business Support Office Manchester. Big takeaway being that the healthcare world is constantly adapting to new issues and changing needs within populations. More than ever we need to get insights from sensitive real world data to address this. 🗣️ Data Driven Healthcare: showing the NVvP Podiatry case with Roy and Toon Segers. Great seeing everyone's contributions for how #Data & #AI can help achieve cross-domain & cross-regional #cooperation in healthcare. 🏫 TPMPC 2024: Meilof Veeningen presenting our work with Publiek Vervoer Groningen Drenthe in front of some of the leading minds in MPC at Technische Universität Darmstadt with ENCRYPTO Group. ⚔️ HLTH Europe: we were stoked to be in the Top 10 finalists out of 400 applicants in the startup pitch competition, presented by Roderick Rodenburg. Congrats to Ally Health and well done to the other finalists! Exploris Health AG | Fava Health | Juisci | Neu Health | Orakl Oncology | Preview Health | theblood | Virtonomy.io 🎤 TNW Conference: Ian Wachters pitching to an eagerly listening crowd. Big thanks to everyone involved and to all the new people we've met along the way! 👇 𝗥𝗲𝗺𝗶𝗻𝗱𝗲𝗿 👇 We're presenting at nicpet's Eighth Network Meeting this coming Monday with Gemeente Rotterdam. Don't miss out!: https://hubs.li/Q02DGGFj0

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
    +1

To view or add a comment, sign in

Explore topics